BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genzyme Corporation 

500 Kendall Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-252-7500 Fax: 617-252-7600


SEARCH JOBS



About Genzyme

Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.

Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.

Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis.

Learn more at www.jobsatgenzyme.com.

Follow our jobs on Twitter www.twitter.com/genzymejobs.

Follow us on LinkedIn http://www.linkedin.com/company/genzyme.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


 Key Statistics


Email: AskGenzyme@genzyme.com
Ownership: Public

Web Site: Genzyme Corporation
Employees:
Symbol: GENZ
 



Industry
Biotechnology


Collaborations

Medtronic, Inc.  Cardiac Cell Therapy

Cambridge Antibody Technology Group PLC   Antibodies against TGF-ß

Dyax Corp.  Hereditary Angioedema





 Company News
Third Rock Ventures Taps Alnylam Pharmaceuticals (ALNY) CEO, Genzyme Corporation (GENZ)-ImClone Systems (LLY) Vets, as Venture Partners 5/14/2013 7:57:36 AM    More...
Genzyme Corporation (GENZ) Release: Once-Daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study 4/25/2013 9:22:38 AM    More...
Genzyme Corporation (GENZ) Convenes 13th European Fabry Disease Roundtable 4/18/2013 7:26:40 AM    More...
Genzyme Corporation (GENZ)'s AUBAGIO® Approved in Argentina for MS 4/8/2013 7:16:26 AM    More...
Effect of Genzyme Corporation (GENZ)'s LEMTRADA Maintained in Patients Beyond Two-Year Pivotal MS Studies 3/28/2013 9:15:49 AM    More...
Growing Uptake of Genzyme Corporation (GENZ)'s Aubagio at Three Months Post-Launch Is Likely Driven by Perceived Product Convenience Even As Neurologists Search to Identify Appropriate Candidates, According to a Recent BioTrends Report 3/6/2013 8:32:39 AM    More...
Genzyme Corporation (GENZ)'s Head of Rare Diseases Honored by the Genetic Disease Foundation 3/4/2013 9:57:12 AM    More...
Genzyme Corporation (GENZ) Touts Positive Ph3 Drug Data 2/15/2013 9:23:54 AM    More...
Sanofi (France) (SAN.PA) to Invest $59.3 Million in Genzyme Corporation (GENZ)'s Waterford Campus 2/13/2013 7:39:58 AM    More...
Biotech Firms Like Amgen (AMGN), Genzyme Corporation (GENZ) Race for Manufacturing Breakthrough 1/30/2013 7:44:23 AM    More...
12345678910...